On this page
The editorial assessment
The named BPC card should stay separate from the rest of the peptide menu. Which ingredients, route, quantity and renewal charge will appear in the written prescription and order?
- Published payment basis
- $265/month advertised BPC-157 card
- Preparation record
- BPC-157 separate from other peptide or blend entries
- Care process
- Licensed-clinician review and ongoing messaging described
- Access setting
- Online intake; individual prescription required
What is documented
- The named BPC card should stay separate from the rest of the peptide menu
- A product or assessment record is available for a concrete follow-up question
What needs an answer
- Which ingredients, route, quantity and renewal charge will appear in the written prescription and order?
- Published information does not establish a personal prescription or clinical outcome
The BPC card is the relevant price record
YourEra's $265 monthly entry is attached to BPC-157, while other peptides and blends occupy separate cards. That supports a molecule-specific advertised figure, not an inference about identical quantities or terms across the catalogue. Ongoing messaging describes access to care rather than a clinical outcome. The consultation checklist should establish the actual prescribed supply and the scope of included follow-up.
The unresolved term
Published information does not establish a personal prescription or clinical outcome
A contrasting service record
The CareFirst Specialty Pharmacy service review documents another purchasing structure: a capsule listing cannot be substituted for an injection order or a consultation bundle. That distinction changes which components belong in a like-for-like comparison.
On the record
The documents supporting this report.
- YourEra official BPC-157 service or pricing recordCompany website